Company / Cash per Share
Integra Lifesciences Holdings Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.93
FY2025
5-year range
$2.93 / $5.94
FY2021-FY2025
Trend
-0.8%
vs FY2024
Sector context
#77 of 146
Health Care
What the data says
At $2.93, Integra Lifesciences Holdings's cash per share ranks #77 of 146 in the Health Care sector. Cash per Share has declined for 4 consecutive years, from $5.94 in FY2021 to $2.93 in FY2025.
Based on SEC 10-K filings.
2.93 in FY2025 with a 5-year CAGR of -12.2%.
Declined from $3.23 to $2.93 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -18.3%
- 5-Year CAGR
- -12.2%
- 10-Year CAGR
- -
Sector benchmark
#77 of 146 in Health CareTop 53% of 146This company $2.93 Sector average $27.70
▼
-89.4% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's cash per share has declined for 4 consecutive years.
- In FY2025, cash per share decreased 0.8% year-over-year.
- Ranks #77 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.93 | -0.8% |
| FY2024 | $2.95 | -8.8% |
| FY2023 | $3.23 | -39.7% |
| FY2022 | $5.36 | -9.7% |
| FY2021 | $5.94 | +6.1% |
| FY2020 | $5.60 | +122.6% |
| FY2019 | $2.51 | +43.4% |
| FY2018 | $1.75 | +22.6% |
| FY2017 | $1.43 | +95.9% |
| FY2016 | $0.73 | -56.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026